Abiopharma

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

monday.com Announces Second Quarter 2026 Results

Silvia Outperforms Every Major AI Model on Tax and Open Sources the Benchmark Test

Ceva, Inc. Announces Second Quarter 2026 Financial Results

MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

HEINZ Introduces the Love Lid, the First Customizable Ketchup Lid Made for Summers Favorite Foods

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

Kaspi.kz 2Q & 1H 2026 Financial Results